Chromosomal abnormalities are the single most common cause of miscarriage, accounting for roughly 40 to 55 percent of first-trimester pregnancy losses depending on the population studied and the testing method used. Most of these errors arise randomly during the formation of the egg or very early cell divisions of the embryo, and they almost always prevent normal development. But the relationship between chromosomal problems and miscarriage risk is more nuanced than that summary suggests, with implications for maternal age, paternal health, recurrence, and even what a chromosomally abnormal loss signals about your chances next time.
How Often Chromosomal Problems Are Behind a Miscarriage
When tissue from first-trimester miscarriages is tested, chromosomal abnormalities show up with striking consistency across different countries and study designs. A review of 1,000 first-trimester miscarriages using conventional testing found chromosomal problems in just over half the cases.1PubMed Central. Chromosomal abnormalities in products of conception of first-trimester miscarriages detected by conventional cytogenetic analysis: a review of 1000 cases A Greek single-center study found abnormal results in about 42 percent of samples,2PubMed Central. Incidence and Types of Chromosomal Abnormalities in First Trimester Spontaneous Miscarriages: a Greek Single-Center Prospective Study while a Thai study placed the figure closer to 51 percent.3PubMed Central. Incidence and Types of Fetal Chromosomal Abnormalities in First Trimester of Thai Pregnant Women between Miscarriages and Intrauterine Survivals These numbers vary partly because of how the tissue is analyzed and partly because of the age distribution of the women studied, but the general picture is consistent: somewhere around half of early losses are chromosomally driven.
A systematic review that pooled data across multiple studies found that the prevalence of fetal chromosomal anomalies was about 45 percent in sporadic miscarriages and around 39 percent in women who had experienced recurrent losses.4Fertility and Sterility. Genetic causes of sporadic and recurrent miscarriage – Section: Genetics: A primary contributor to miscarriage That slight drop in the recurrent group is meaningful, and we will come back to what it implies.
Which Chromosomal Errors Come Up Most
Not all chromosomal problems are created equal. The large review of 1,000 miscarriages broke down the types among the abnormal samples: about 60 percent were trisomies (an extra copy of a chromosome), 22 percent were polyploidies (an entire extra set of chromosomes, usually from fertilization errors), roughly 8 percent were monosomies (a missing chromosome), 7 percent had unbalanced structural changes, and about 4 percent had multiple abnormalities at once.1PubMed Central. Chromosomal abnormalities in products of conception of first-trimester miscarriages detected by conventional cytogenetic analysis: a review of 1000 cases
Trisomies dominate the list because they are the most frequent consequence of errors during egg cell division. Among trisomies, some chromosomes are overrepresented. In one study of pregnancies where the gestational sac formed but no embryo developed, trisomy 16 was the most common finding, appearing in 15 percent of those samples, followed by trisomies 22, 15, and 19.5PubMed. Chromosomal abnormalities study for anembryonic pregnancy by BACs-on-Beads technique Trisomy 16 is virtually always lethal; it causes very early loss and is essentially never seen in live births, unlike trisomy 21 (Down syndrome), which allows survival. The point is that most trisomies causing miscarriage involve chromosomes where an extra copy is so disruptive that the pregnancy simply cannot continue.
Monosomies in miscarriage tissue are overwhelmingly monosomy X, meaning only one sex chromosome is present. This condition, when it does result in a live birth, leads to Turner syndrome, but the vast majority of monosomy X conceptions end in early loss. Polyploidy, in which the embryo has 69 or 92 chromosomes instead of the normal 46, usually stems from an egg being fertilized by two sperm at once or from a failure during egg maturation. These pregnancies rarely develop far.
Why Maternal Age Is the Biggest Risk Factor
The link between a woman’s age and the chance of a chromosomally abnormal pregnancy is one of the most consistent findings in reproductive medicine. Eggs are particularly prone to errors during the cell division process that produces them, and those errors become far more common with age.6PubMed. Mechanisms of oocyte aneuploidy associated with advanced maternal age The mechanisms behind this include the breakdown of structures that hold chromosomes together during division and problems with the spindle fibers that pull chromosomes apart, both of which worsen over time.7PubMed Central. Impact of Maternal Age on Oocyte and Embryo Competence
The practical result is that a woman in her early 20s has a miscarriage rate of roughly 10 to 15 percent per recognized pregnancy, while a woman in her early 40s faces a rate of 40 percent or higher. Much of that increase is driven by a rising proportion of chromosomally abnormal embryos. By age 40, the majority of embryos produced in any given cycle carry a chromosomal error. This is not about health or fitness in any conventional sense; it reflects a biological clock built into how human eggs are stored and matured over decades.
The Paternal Side of the Equation
Conversations about chromosomal miscarriage risk tend to focus on eggs, but sperm contribute half the embryo’s genetic material, and paternal factors do matter. A systematic review and meta-analysis found that advanced paternal age is associated with an increased risk of miscarriage.8PubMed Central. Advanced paternal age is associated with an increased risk of spontaneous miscarriage: a systematic review and meta-analysis However, the mechanism appears to be different from what happens in eggs. Because sperm are continuously produced rather than stored for decades, they are less vulnerable to the kind of chromosome-sorting errors that plague older eggs. Instead, the paternal age effect seems to work mainly through increased DNA fragmentation in sperm, where the DNA becomes damaged over time due to oxidative stress and reduced repair capacity.9PubMed Central. Advanced paternal age is associated with an increased risk of spontaneous miscarriage: a systematic review and meta-analysis – Section: Discussion
Beyond age, male partners can carry structural chromosome rearrangements, such as balanced translocations, where pieces of chromosomes have swapped places. A man with a balanced translocation is perfectly healthy because all his genetic information is present, just reshuffled. But when his cells produce sperm, the reshuffled chromosomes can sort unevenly, creating sperm with missing or extra genetic material. Couples where one partner carries a balanced translocation face a substantially elevated risk of recurrent miscarriage.10PubMed Central. The paternal role in pregnancy loss About 2 to 5 percent of couples with recurrent pregnancy loss have an identifiable parental chromosomal rearrangement in one partner.4Fertility and Sterility. Genetic causes of sporadic and recurrent miscarriage – Section: Genetics: A primary contributor to miscarriage
Recurrent Miscarriage Is Not Always the Same Problem Repeating
After two or three losses, it is natural to assume something specific is wrong. And sometimes there is: a parental translocation, a uterine abnormality, a hormonal disorder. But the evidence reveals a less intuitive picture. The rate of chromosomal abnormalities in tissue from recurrent miscarriages is similar to the rate in sporadic losses, around 39 percent versus 45 percent.4Fertility and Sterility. Genetic causes of sporadic and recurrent miscarriage – Section: Genetics: A primary contributor to miscarriage Losses due to random new chromosomal errors occur at similar frequencies whether you have experienced one loss or several.11PubMed Central. Genetic considerations in recurrent pregnancy loss
This means that a woman who has had three consecutive miscarriages may have had three separate bad-luck chromosomal events rather than a single ongoing problem. But as the number of losses mounts, the probability that all of them are purely random decreases, and the likelihood that a non-chromosomal factor is contributing goes up. Those other factors include uterine structural issues, hormonal imbalances, immune-related problems, and blood-clotting disorders. This is why clinical guidelines typically recommend a thorough workup after two or three consecutive losses rather than after a single one.
A Chromosomal Loss Can Actually Be a Good Prognostic Sign
This is perhaps the most counterintuitive finding in the field. Among women with recurrent miscarriage, those whose losses were chromosomally abnormal tend to have better outcomes in subsequent pregnancies than those whose losses were chromosomally normal. A 2025 study of women with unexplained recurrent pregnancy loss found that after one chromosomally abnormal miscarriage, about 86 percent went on to have a live birth. By contrast, women whose single tested miscarriage was chromosomally normal had a live birth rate of about 61 percent.12PubMed Central. Chromosomal miscarriage and pregnancy outcomes in recurrent pregnancy loss – Section: Results
The logic behind this makes sense once you think about it. If your miscarriage was caused by a random chromosomal error in the embryo, that error was a one-off event that tells us nothing about your body’s ability to carry a pregnancy. It was bad luck, essentially a coin flip that came up wrong. But if the miscarriage tissue was chromosomally normal and the pregnancy still failed, that raises the question of whether something in the uterine environment, the immune system, or the hormonal milieu prevented a genetically healthy embryo from thriving. The study found that having a history of chromosomally abnormal losses was a significant predictor of future live birth, suggesting that these random events do not impair reproductive potential going forward.12PubMed Central. Chromosomal miscarriage and pregnancy outcomes in recurrent pregnancy loss – Section: Results
This finding has real clinical value: it can be deeply reassuring for couples whose tested loss turns out to be chromosomally driven. And it is one of the strongest arguments for testing miscarriage tissue when possible, because the result changes both the prognosis and the direction of any further investigation.
How Testing Works After a Loss
If you experience a miscarriage and your doctor recommends chromosomal testing of the pregnancy tissue, several methods exist, and they are not all equally good at catching abnormalities. Traditional karyotyping, which involves growing cells from the tissue and photographing the chromosomes, has been the standard for decades. But it has limitations: it requires living cells that may not always grow in the lab, and it can miss smaller genetic changes.
Chromosomal microarray analysis, a newer approach that scans the entire genome for gains or losses of genetic material, outperforms karyotyping on several fronts. In a study of miscarriage tissue, microarray analysis detected abnormalities in about 55 percent of samples, including roughly 7 percent of changes that conventional karyotyping would have missed entirely.13PubMed Central. Application of chromosomal microarray analysis in products of miscarriage – Section: Results In a large study of stillbirths, microarray yielded usable results more often than karyotyping, at about 87 percent versus 71 percent, and identified more genetic abnormalities across the board.14PubMed Central. Karyotype versus Microarray Testing for Genetic Abnormalities after Stillbirth – Section: RESULTS
An emerging alternative aims to avoid tissue collection altogether. Researchers have begun extracting cell-free fetal DNA from the mother’s blood after a miscarriage and analyzing it for chromosomal abnormalities using sequencing technology.15Fertility and Sterility. Non-invasive miscarriage chromosome analysis using cell-free fetal DNA sequencing from maternal blood This non-invasive approach is still in early-stage research, but if validated, it could make testing far more accessible, particularly when tissue samples are incomplete or unavailable.
Preimplantation Genetic Testing in IVF
For couples using in vitro fertilization, preimplantation genetic testing for aneuploidies (PGT-A) offers a way to screen embryos for chromosomal problems before transfer. The idea is straightforward: a few cells are biopsied from the embryo at the blastocyst stage, analyzed for the correct number of chromosomes, and only embryos with a normal result are selected for transfer.
In high-risk groups, the results can be dramatic. Among women with recurrent miscarriage, one study found that PGT-A reduced early pregnancy loss from 75 percent to about 18 percent and increased the live birth rate per transfer from roughly 13 percent to 50 percent.16PubMed Central. The impact of preimplantation genetic testing for aneuploidies (PGT-A) on clinical outcomes in high risk patients – Section: Results In women aged 38 and older with unexplained recurrent miscarriage, PGT-A raised the live birth rate from about 18 percent to 47 percent and cut the early miscarriage rate from 40 percent to about 17 percent.17PubMed Central. Analysis of pregnancy outcomes in patients with unexplained recurrent miscarriage assisted by IVF/ICSI with or without PGT-A – Section: RESULTS
PGT-A is not without controversy, though. In younger women without a history of recurrent loss, the benefit is less clear, and some clinicians argue the biopsy process itself introduces a small risk. There is also the question of what happens when all the embryos in a cycle test abnormal, which becomes increasingly common with age. A cycle with no transferable embryos is emotionally and financially costly, even if it avoids a miscarriage. Still, for specific populations, particularly older women and those with repeated losses, the evidence for reduced miscarriage rates is compelling.
Mosaic Embryos and the Gray Zone
PGT-A results are not always binary. Some embryos come back as “mosaic,” meaning a mix of chromosomally normal and abnormal cells was detected in the biopsy sample. For years, mosaic embryos were routinely discarded. That practice has shifted as accumulating data show that many mosaic embryos can result in healthy live births.
Outcomes depend heavily on the type and degree of mosaicism. Embryos with low-level mosaicism or segmental mosaicism (where only a portion of a chromosome is affected rather than a whole chromosome) tend to have pregnancy outcomes comparable to fully normal embryos. By contrast, embryos with high-level whole-chromosome mosaicism show markedly reduced pregnancy rates.18Human Reproduction. L26/P-663 Clinical and ongoing pregnancy outcomes after single euploid and mosaic blastocyst transfer according to mosaic type and level The transfer of mosaic embryos is increasingly considered when no fully normal embryos are available, though it requires careful counseling about the lower but real chance of success and the need for additional monitoring during pregnancy.
When the Cause Is Not Chromosomal
Because chromosomal problems account for roughly half of first-trimester losses, it follows that roughly half have other causes. This other half is where the diagnostic challenge lies. The non-chromosomal contributors include uterine structural anomalies like a septum dividing the uterine cavity, hormonal problems such as thyroid dysfunction or poorly controlled diabetes, immune factors including antiphospholipid syndrome, blood clotting disorders, and infections. Environmental exposures to endocrine-disrupting chemicals have also been identified as a potential contributor, given their capacity to interfere with the hormonal environment around implantation.
For couples dealing with recurrent loss, the distinction matters. If every tested loss has been chromosomally abnormal, the losses are likely random, the prognosis is good, and aggressive investigation may not change management. If a loss comes back chromosomally normal, that is when a deeper dive into uterine anatomy, immune function, and hormonal health becomes most important. This does not mean chromosomally normal losses are untreatable; many of the underlying causes have effective interventions. It simply means the investigation points in a different direction.
What Parental Carrier Testing Involves
When couples experience recurrent loss, one standard part of the workup is a blood test called a karyotype on both partners. This test looks at the parents’ own chromosomes for structural rearrangements, primarily balanced translocations and inversions. As noted earlier, carriers of balanced rearrangements are themselves healthy, but they produce a higher-than-normal proportion of chromosomally unbalanced eggs or sperm. Identifying a parental rearrangement does not change the couple’s health, but it reshapes the conversation about future pregnancies. Options may include natural conception with awareness that some proportion of pregnancies will be lost, IVF with PGT for structural rearrangements (PGT-SR) to select embryos that inherited a balanced or normal chromosome set, or donor gametes in rare cases.
The yield of parental karyotyping is modest: only about 2 to 5 percent of couples with recurrent loss will have an identifiable rearrangement.4Fertility and Sterility. Genetic causes of sporadic and recurrent miscarriage – Section: Genetics: A primary contributor to miscarriage But for those couples, the finding is transformative because it explains the pattern and opens specific treatment paths. For the remaining majority, negative parental karyotypes are themselves informative, ruling out one important category of risk and redirecting attention elsewhere.